DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Minodronic acid is an investigational drug.
There have been 4 clinical trials for Minodronic acid. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2004.
The most common disease conditions in clinical trials are Osteoporosis, Bone Diseases, and Osteoporosis, Postmenopausal. The leading clinical trial sponsors are Astellas Pharma Inc, Ono Pharmaceutical Co. Ltd, and Wuhan Union Hospital, China.
Recent Clinical Trials for Minodronic acid
|Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the Pharmacokinetics||Wuhan Union Hospital, China||Phase 1|
|A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation||Ono Pharma USA Inc||Phase 1|
|A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation||Astellas Pharma Inc||Phase 1|